News Agency News Aggregator Journalist/Editor Broking House Others
#Pfizer CEO sees likely need for 3rd #COVID vaccine dose between 6-12 months (From Agencies) #CovidVaccine #PfizerVaccine #coronavirus
Pfizer CEO Albert Bourla says people will "likely" need a booster dose of a #Covid-19 vaccine within 12 months of getting fully vaccinated. He also said it's possible people will need to get vaccinated against the virus annually.
#Breaking | Pfizer CEO says third Covid vaccine dose likely needed within 12 months: @cnbc
So far, the WHO has issued emergency listings for Pfizer and BioNTech's #COVID19 vaccine, as well as versions of AstraZeneca's vaccine made by the Serum Institute of India and South Korea's AstraZeneca-SKBio.
Watch our DARLING #PFIZER !!!!! Any PANIC ,Only Mantra is buy and buy !!!!! →From 4500 level telling us something big cooking →Big Neta's knows.......so need to do scam.......buy stock and mint millions !!!!!
Shortages have led the government to allow vaccines approved by foreign regulators easier entry into the market. Across the globe, Oxford-AstraZeneca’s vaccine is the most sought after, closely followed by Pfizer-BioNTech, data shows Read #MintNewsletter
#COVID-19 | Kiran Mazumdar Shaw (@kiranshaw) expects issue w.r.t Remdesivir to settle by April end/early May, Itolizumab & Tocilizumab issues by mid-May. She believes, Moderna, Pfizer vaccines coming into India will be dependent on pricing
The first study to directly compare immune reactions between #Pfizer's and #AstraZeneca's covid vaccines has found similarly strong antibody responses in over 80-year-olds after a first dose of either shot, UK scientists said.
The European Union, grappling with the potential loss of Johnson & Johnson Covid-19 vaccines, will buy an additional 50 million doses from BioNTech and Pfizer for the quarter, and is in talks to purchase up to 1.8 billion more doses over the next two years
Coming Up At 7 & 9:30 PM | K VijayRaghavan, @PrinSciAdvGoI tells @ShereenBhan, 'India should soon have applications from J&J, Novavax.' Adds 'Pfizer, Moderna have made long-term commitments over the next few months, and they are not likely to apply in India.'